Hansa Biopharma AB Net Asset Quality Index
Hansa Biopharma AB net asset quality index. Hansa Biopharma AB (HNSA) has a Net Asset Quality Index of -52.7% as of June 2025. This metric measures the proportion of total assets financed by shareholders' equity — total assets of Skr837.27 Million minus total liabilities of Skr1.28 Billion yields net assets of Skr-441.06 Million. A higher index indicates a stronger, lower-leverage balance sheet. See what is Hansa Biopharma AB's book value for net asset value and shareholders' equity analysis.
Quality Index
Net Assets
Total Assets
Total Liabilities
Net Asset Quality Index of Hansa Biopharma AB (2008–2024)
Net asset quality index of Hansa Biopharma AB from 2008 to 2024. This chart shows how Hansa Biopharma AB's Net Asset Quality Index has evolved across 17 annual periods from 2008 to 2024. As of June 2025, the index stands at -52.7%, representing net assets of Skr-441.06 Million against total assets of Skr837.27 Million SEK. Check Hansa Biopharma AB strategic asset allocation index to assess the company's strategic physical and investment asset allocation.
Hansa Biopharma AB Net Asset Quality Index by Year (2008–2024)
Hansa Biopharma AB net asset quality index by year from 2008 to 2024. The table below presents the year-by-year Net Asset Quality Index for Hansa Biopharma AB from 2008 to 2024, covering 17 annual filings. Each row shows total assets, total liabilities, net assets, the quality index percentage, and the change in percentage points compared to the prior year. For live market cap and overall valuation, see HNSA market cap.
| Year | Quality Index | Net Assets (SEK) | Total Assets | Total Liabilities | Change (pp) |
|---|---|---|---|---|---|
| 2024 | -73.7% | Skr-589.83 Million | Skr800.64 Million | Skr1.39 Billion | ▼ -57.2 pp |
| 2023 | -16.5% | Skr-167.88 Million | Skr1.02 Billion | Skr1.19 Billion | ▼ -52.2 pp |
| 2022 | 35.7% | Skr602.91 Million | Skr1.69 Billion | Skr1.08 Billion | ▼ -39.1 pp |
| 2021 | 74.8% | Skr757.57 Million | Skr1.01 Billion | Skr255.24 Million | ▼ -11.8 pp |
| 2020 | 86.6% | Skr1.24 Billion | Skr1.43 Billion | Skr192.37 Million | ▲ +1.9 pp |
| 2019 | 84.7% | Skr562.82 Million | Skr664.24 Million | Skr101.42 Million | ▼ -6.3 pp |
| 2018 | 91.0% | Skr859.88 Million | Skr944.82 Million | Skr84.94 Million | ▼ -1.7 pp |
| 2017 | 92.7% | Skr630.66 Million | Skr680.41 Million | Skr49.75 Million | ▲ +1.4 pp |
| 2016 | 91.3% | Skr283.69 Million | Skr310.67 Million | Skr26.98 Million | ▼ -3.1 pp |
| 2015 | 94.4% | Skr211.53 Million | Skr224.09 Million | Skr12.56 Million | ▲ +2.7 pp |
| 2014 | 91.7% | Skr49.80 Million | Skr54.31 Million | Skr4.51 Million | ▲ +1.7 pp |
| 2013 | 90.0% | Skr45.68 Million | Skr50.78 Million | Skr5.10 Million | ▼ -6.2 pp |
| 2012 | 96.1% | Skr63.24 Million | Skr65.80 Million | Skr2.56 Million | ▲ +11.2 pp |
| 2011 | 84.9% | Skr34.71 Million | Skr40.90 Million | Skr6.19 Million | ▼ -0.2 pp |
| 2010 | 85.1% | Skr32.17 Million | Skr37.80 Million | Skr5.64 Million | ▲ +19.8 pp |
| 2009 | 65.3% | Skr24.92 Million | Skr38.15 Million | Skr13.23 Million | ▼ -25.5 pp |
| 2008 | 90.8% | Skr40.73 Million | Skr44.87 Million | Skr4.13 Million | — |